CoreWeave (CRWV) Stock Falls 3% As Meta AI Threat and Insider Sales Weigh on Sentiment

TLDR

• CoreWeave stock dropped 3.4% to $83.53, hitting an intraday low of $79.46, with trading volume down 20% from its average session
• Wall Street maintains a Moderate Buy consensus with an average price target of $135, with some targets as high as $250
• Meta’s potential entry into the AI cloud/compute market is spooking investors, raising concerns about long-term competition for CoreWeave
• Insiders have sold over $3 billion worth of CRWV stock in the past 90 days, though most sales are tied to pre-arranged tax withholding plans
• CoreWeave missed Q1 earnings estimates, posting EPS of -$1.40 vs the expected -$1.17, though revenue surged 111.6% year-over-year to $2.08 billion

---

CoreWeave (CRWV) dropped 3.4% on Tuesday, trading at $83.53 after dipping as low as $79.46 intraday. The stock had closed the prior session at $86.46.

CoreWeave, Inc. Class A Common Stock, CRWV

Volume came in at roughly 23 million, about 20% below the stock’s average session pace — suggesting the move wasn’t driven by a surge of panic selling.

The stock is up 26% year-to-date but down 41% over the past year, sitting well below its 50-day moving average of $106.86.

The day’s decline came against a backdrop of growing investor concern around two fronts: Meta’s push into AI compute, and a steady stream of insider selling.

A Bloomberg report flagged that Meta is considering selling AI computing power and raw computing capacity to outside customers — a move that would put it in direct competition with CoreWeave’s core business.

Rosenblatt maintained its Buy rating and kept a $250 price target, arguing the Meta threat is overstated. Wolfe Research and Evercore ISI both reiterated Outperform ratings with $150 price targets.

Insider Selling Under the Microscope

Insider sales have caught attention. In the past 90 days, insiders have sold over $3 billion worth of CRWV stock.

Most recently, General Counsel Kristen J. McVeety sold 22 shares for $1,889 on July 6, under a Rule 10b5-1 plan adopted in May 2025.

Earlier, insider Brian Venturo sold 76,912 shares on July 1 at an average of $86.99, totaling roughly $6.69 million. That represented a 21% reduction in his position.

Insider Brannin McBee sold 56,707 shares on June 30 at $95.69, for about $5.43 million — a 14.9% cut to his stake.

Both sales were executed under pre-arranged Rule 10b5-1 plans to cover tax obligations on vesting equity. That’s a routine mechanism, but the scale has still drawn scrutiny.

Earnings Miss Still Fresh

CoreWeave’s last earnings report, from May 7, didn’t help sentiment. The company posted EPS of -$1.40, missing the -$1.17 consensus by $0.23.

Revenue hit $2.08 billion, up 111.6% year-over-year. Strong top-line growth, but the profitability gap remains wide — net margin sits at -25.57%.

Analysts on average forecast full-year EPS of -$4.57.

Despite the miss, several analysts argued the selloff is overdone. BNP Paribas has the highest price target on the Street at $192, while Cantor Fitzgerald sits at $167. Wells Fargo raised its target to $155 in May.

Out of 35 analysts covering the stock, 21 rate it a Buy, 12 a Hold, and 2 a Sell.

The company’s debt-to-equity ratio stands at 3.68, with a current ratio of just 0.31 — a balance sheet that carries real risk alongside the growth story.

CoreWeave’s market cap sits at approximately $37–45 billion, depending on the session. It launched ARIA, an AI-enabled research agent, this week — though analysts don’t see it as a near-term market mover.